Influence of the antipsychotic drug pipamperone on the expression of the dopamine D4 receptor

Life Sciences

Volumn 80, Issue 1, 2006, Pages 74-81

  Van Craenenbroeck, Kathleen ^a,c   Gellynck, Evelien ^a   Lintermans, Béatrice ^a   Leysen, Josée E ^b   Van Tol, Hubert H M ^c   Haegeman, Guy ^a   Vanhoenacker, Peter ^a  

^a GHENT UNIVERSITY   (Belgium)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Chaperone; Dopamine D4 receptor; Epstein Barr virus; G protein coupled receptor; Inducible expression; Pipamperone

Indexed keywords

BUTYRIC ACID; CHAPERONE; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOXYCYCLINE; LIGAND; MEMBRANE PROTEIN; MESSENGER RNA; NEUROLEPTIC AGENT; PIPAMPERONE; SEROTONIN 2A ANTAGONIST; SEROTONIN 2A RECEPTOR; TETRACYCLINE; TRICHOSTATIN A;

ARTICLE; CONTROLLED STUDY; EMBRYO; EPISOME; EPSTEIN BARR VIRUS; EXPRESSION VECTOR; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FOLDING; RECEPTOR UPREGULATION; RNA SYNTHESIS;

ANIMALS; ANTIPSYCHOTIC AGENTS; BUTYROPHENONES; CELLS, CULTURED; CHO CELLS; CRICETINAE; HUMANS; MICE; MOLECULAR CHAPERONES; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, DOPAMINE D2; RNA, MESSENGER;

HUMAN HERPESVIRUS 4;

EID: 33751348051     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.08.024     Document Type: Article

References (41)

1. Condreay J.P., Witherspoon S.M., Clay W.C., and Kost T.A. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proceedings of the National Academy of Science of the United States of America 96 1 (1999) 127-132
2. D'Souza U.M., Russ C., Tahir E., Mill J., McGuffin P., Asherson P.J., and Craig I.W. Functional effects of a tandem duplication polymorphism in the 5′ flanking region of the DRD4 gene. Biological Psychiatry 56 9 (2004) 691-697
3. Dyson P.J., and Farrel P.J. Chromatin structure of Epstein-Barr virus. Journal of General Virology 66 (1985) 1931-1940
4. Ellgaard L., and Helenius A. Quality control in the endoplasmic reticulum. Nature Reviews. Molecular Cell Biology 4 3 (2003) 181-191
5. Ellgaard L., Molinari M., and Helenius A. Setting the standards: quality control in the secretory pathway. Science 286 5446 (1999) 1882-1888
6. Gossen M., and Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proceedings of the National Academy of Science of the United States of America 89 (1992) 5547-5551
7. Gossen M., Freundlieb S., Bender G., Muller G., Hillen W., and Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science 268 5218 (1995) 1766-1769
8. Hug H., Costas M., Staeheli P., Aebi M., and Weissmann C. Organization of the Murine Mx gene and characterization of its interferon- and virus-inducible promoter. Molecular and Cellular Biology 8 (1988) 3065-3079
9. Kopito R.R. Biosynthesis and degradation of CFTR. Physiological Reviews 79 1 Suppl (1999) S167-S173
10. 125I] 2′-iodospiperone. Psychopharmacology (Berlin) 110 1-2 (1993) 27-36
11. Lichter J.B., Barr C.L., Kennedy J.L., Van Tol H.H.M., Kidd K.K., and Livak K.J. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Human Molecular Genetics 2 6 (1993) 767-773
12. Loo T.W., and Clarke D.M. Correction of defective protein kinesis of human P-glycoprotein mutants by substrates and modulators. Journal of Biological Chemistry 272 2 (1997) 709-712
13. Lu M., Staszewski L., Echeverri F., Xu H., and Moyer B.D. Endoplasmic reticulum degradation impedes olfactory G-protein coupled receptor functional expression. BioMed Central Cell Biology 5 1 (2004) 34
14. Marchese A., Chen C., Kim Y.M., and Benovic J.L. The ins and outs of G protein-coupled receptor trafficking. Trends in Biochemical Sciences 28 7 (2003) 369-376
15. Melhus H., Laurent B., Rask L., and Peterson P.A. Ligand-dependent secretion of rat retinol-binding protein expressed in HeLa cells. Journal of Biological Chemistry 267 17 (1992) 12036-12041
16. 2-receptors, a promising tracer for 'gamma'-emission tomography. Journal of Labelled Compounds & Radiopharmaceuticals 34 9 (1994) 795-806
17. Morello J.P., Petaja-Repo U.E., Bichet D.G., and Bouvier M. Pharmacological chaperones: a new twist on receptor folding. Trends in Pharmacological Sciences 21 12 (2000) 466-469
18. 4 receptor: one decade of research. European Journal of Pharmacology 405 1-3 (2000) 303-327
19. Oak J.N., Lavine N., and Van Tol H.H.M. Dopamine D(4) and D(2L) receptor stimulation of the mitogen-activated protein kinase pathway is dependent on trans-activation of the platelet-derived growth factor receptor. Molecular Pharmacology 60 1 (2001) 92-103
20. Petaja-Repo U.E., Hogue M., Bhalla S., Laperriere A., Morello J.P., and Bouvier M. Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation. EMBO Journal 21 7 (2002) 1628-1637
21. Sato S., Ward C.L., Krouse M.E., Wine J.J., and Kopito R.R. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. Journal of Biological Chemistry 271 2 (1996) 635-638
22. Schotte A., Janssen P.M.F., Gommeren W., Luyten W.H.M.L., Van Gompel P., Lesage A.S., De Loore K., and Leysen J.E. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology 124 (1996) 57-73
23. Schubert U., Anton L.C., Gibbs J., Norbury C.C., Yewdell J.W., and Bennink J.R. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404 6779 (2000) 770-774
24. Skacel N., Menon L.G., Mishra P.J., Peters R., Banerjee D., Bertino J.R., and Abali E.E. Identification of amino acids required for the functional up-regulation of human dihydrofolate reductase protein in response to antifolate treatment. Journal of Biological Chemistry 280 24 (2005) 22721-22731
25. Spencer V.A., and Davie J.R. Role of covalent modifications of histones in regulating gene expression. Gene 240 1 (1999) 1-12
26. Tamarappoo B.K., and Verkman A.S. Defective aquaporin-2 trafficking in nephrogenic diabetes insipidus and correction by chemical chaperones. Journal of Clinical Investigation 101 10 (1998) 2257-2267
27. Tsai B., Ye Y., and Rapoport T.A. Retro-translocation of proteins from the endoplasmic reticulum into the cytosol. Nature Reviews. Molecular Cell Biology 3 4 (2002) 246-255
28. Van Craenenbroeck K., Vanhoenacker P., Duchau H., and Haegeman G. Molecular integrity and usefulness of episomal expression vectors derived from BK and Epstein-Barr virus. Gene 253 (2000) 293-301
29. Van Craenenbroeck K., Vanhoenacker P., and Haegeman G. Episomal vectors for gene expression in mammalian cells. European Journal of Biochemistry 267 18 (2000) 5665-5678
30. Van Craenenbroeck K., Vanhoenacker P., Leysen J.E., and Haegeman G. Evaluation of the tetracycline- and ecdysone-inducible systems for expression of neurotransmitter receptors in mammalian cells. European Journal of Neuroscience 14 (2001) 968-976
31. Van Craenenbroeck K., Vanhoenacker P., Roman I., and Haegeman G. Orientation-dependent gene expression with Epstein-Barr virus-derived vectors. FEBS Letters 555 (2003) 489-494
32. Van Craenenbroeck K., Vanhoenacker P., and Haegeman G. Emerging DNA viral vectors. In: Cooper D. (Ed). Encyclopedia of the Human Genome vol. 2 (2003), John Wiley & Sons, Ltd. 191-195
33. Van Craenenbroeck K., Clark S., Cox M., Oak J.N., Liu F., and Van Tol H.H.M. Folding efficiency is rate-limiting in dopamine D4 receptor biogenesis. Journal of Biological Chemistry 280 19 (2005) 19350-19357
34. Van Oekelen D., Jurzak M., Van de Wiel D., Van Hecke G., Luyten W.H., and Leysen J.E. Different regulation of rat 5-HT(2A) and rat 5-HT(2C) receptors in NIH 3T3 cells upon exposure to 5-HT and pipamperone. European Journal of Pharmacology 425 1 (2001) 21-32
35. Van Tol H.H.M., Bunzow J.R., Guan H.C., Sunahara R.K., Seeman P., Niznik H.B., and Civelli O. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350 6319 (1991) 610-614
36. Van Tol H.H.M., Wu C.M., Guan H.C., Ohara K., Bunzow J.R., Civelli O., Kennedy J., Seeman P., Niznik H.B., and Jovanovic V. Multiple dopamine D4 receptor variants in the human population. Nature 358 (1992) 149-152
37. Vanden Berghe W., Plaisance S., Boone E., De Bosscher K., Schmitz M.L., Fiers W., and Haegeman G. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. Journal of Biological Chemistry 273 6 (1998) 3285-3290
38. Vanhoenacker P., Gommeren W., Luyten W.H., Leysen J.E., and Haegeman G. Stable, high-level expression of human serotonin receptors in L929 cells using an inducible expression system. Receptors and Channels 5 3-4 (1997) 125-137
39. Vanhoenacker P., Gommeren W., Luyten W.H.M.L., Leysen J.E., and Haegeman G. Optimized expression of serotonin receptors in mammalian cells using inducible expression systems. Gene Therapy and Molecular Biology 3 (1999) 301-310
40. Wang E., Ding Y.C., Flodman P., Kidd J.R., Kidd K.K., Grady D.L., Ryder O.A., Spence M.A., Swanson J.M., and Moyzis R.K. The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus. American Journal of Human Genetics 74 5 (2004) 931-944
41. Yates J.L., Warren N., and Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313 (1985) 812-815